Cardiovascular risk stratification and antihypertensive therapy according to guidelines in the outpatient setting

Jörg Slany1, Günther Nirnberger, Lothar A Pittrow

  • 1Specialist for Internal Medicine, Cardiology & Angiology, Vienna, Austria.

Insights

Austrian physicians often underestimate cardiovascular risk in hypertension patients. Guidelines for combination therapy are not always followed, but candesartan effectively controls blood pressure.

Area of Science:

  • Cardiology
  • Hypertension Management
  • Clinical Practice Guidelines

Background:

  • The adoption of the European Society of Hypertension/European Society of Cardiology (ESH/ESC) 2007 hypertension guidelines and their 2009 reappraisal among Austrian practitioners is not well-documented.
  • A non-interventional trial was conducted to assess the understanding and application of these guidelines in clinical practice.

Purpose of the Study:

  • To evaluate the accuracy of cardiovascular risk categorization by office-based physicians compared to independent adjudication using ESH/ESC charts.
  • To assess compliance with combination therapy recommendations for grade 2 and 3 hypertension.
  • To evaluate the efficacy and tolerability of candesartan treatment.

Main Methods:

  • A non-interventional trial involving 3,488 ambulatory hypertensive patients in Austria.
  • Physicians' risk assessment was compared against an independent risk adjudication using the same data and ESH/ESC methodology.
  • Compliance with combination therapy and the effectiveness of candesartan (alone or with hydrochlorothiazide) were assessed.

Main Results:

  • Physicians incorrectly assessed cardiovascular risk in approximately 60% of patients, with a significant tendency towards underestimation.
  • Despite guidelines recommending initial combination therapy for hypertension ≥160/90 mmHg, 15.4% of these patients received candesartan monotherapy.
  • Candesartan, alone or with hydrochlorothiazide (HCTZ), achieved target blood pressure (≤140/90 mmHg) in 81.6% of patients with grade 1-3 hypertension.

Conclusions:

  • There is a need for improved communication of hypertension guidelines regarding individual risk assessment and therapy algorithms in outpatient settings.
  • Candesartan, as monotherapy or in combination with HCTZ, demonstrates effectiveness and good tolerability for blood pressure control in most hypertensive patients.
Abstract

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...